Urology
Volume 59, Issue 6 , Pages 847-850, June 2002

Prospective evaluation of ureteral stent durability in patients with chronic ureteral obstruction

  • Nejd F Alsikafi

      Affiliations

    • Corresponding Author InformationReprint requests: Nejd F. Alsikafi, M.D., Department of Surgery, Section of Urology, MC6038, University of Chicago Hospitals, 5841 South Maryland Avenue, Chicago, IL 60611 USA
    • Department of Surgery, Section of Urology, University of Chicago Hospitals, Chicago, Illinois, USA
  • ,
  • R.Corey O’Connor

      Affiliations

    • Department of Surgery, Section of Urology, University of Chicago Hospitals, Chicago, Illinois, USA
  • ,
  • Dimitri D Kuznetsov

      Affiliations

    • Department of Surgery, Section of Urology, University of Chicago Hospitals, Chicago, Illinois, USA
  • ,
  • Abraham H Dachman

      Affiliations

    • Department of Radiology, University of Chicago Hospitals, Chicago, Illinois, USA
  • ,
  • Gregory T Bales

      Affiliations

    • Department of Surgery, Section of Urology, University of Chicago Hospitals, Chicago, Illinois, USA
  • ,
  • Glenn S Gerber

      Affiliations

    • Department of Surgery, Section of Urology, University of Chicago Hospitals, Chicago, Illinois, USA

Received 8 November 2001; received in revised form 28 January 2002; accepted 28 January 2002.

Abstract 

Objectives. To prospectively evaluate the durability of ureteral stents in patients with chronic ureteral obstruction.

Methods. Twenty-nine renal units from 22 patients with known chronic ureteral obstruction treated with indwelling ureteral stents were studied at 3, 6, 9, and 12 months after initial stent placement (7 to 8F Percuflex) by abdominal x-ray, serum creatinine, and renal and bladder ultrasonography. Renal ultrasound scans were performed by a single senior radiologist with specific attention paid to any increase in hydronephrosis and to the presence of ureteral jets. The stent was changed when calcifications were seen along the stent on abdominal x-ray, if an increase in serum creatinine occurred, or if any increase in hydronephrosis or absence of ureteral jets was seen on ultrasonography. In addition, the stents were changed if new-onset flank pain and/or pyelonephritis developed. If none of the above occurred, the stents were changed after 12 months.

Results. Two patients died of metastatic cancer, leaving 25 renal units available for follow-up. The mean and median time to stent change were 6 months. At 3, 6, 9, and 12 months, the number of renal units that did not meet the criteria warranting stent change was 18 (72%), 12 (48%), 6 (24%), and 2 (8%), respectively. Only 2 (8%) of 25 renal units did not meet any exclusion criteria at 12 months. The most common reasons for requiring the stent to be changed were new-onset flank pain in 8 (35%), an increase in serum creatinine in 7 (30%), and new-onset or increased hydronephrosis in 7 (30%). No criteria were useful in predicting how long stents could be maintained in an individual patient.

Conclusions. The stents were maintained for more than 6 months in 12 (48%) of 25 renal units. However, very few patients were able to maintain chronic ureteral stents for 12 months without requiring stent change based on our criteria.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0090-4295(02)01599-6

Urology
Volume 59, Issue 6 , Pages 847-850, June 2002